Bloodstream infections in newborns reduce significantly

NewsGuard 100/100 Score

Central line associated bloodstream infections (CLABSIs) in newborns were reduced by 58 percent in less than a year in hospital neonatal intensive care units (NICUs) participating in an Agency for Healthcare Research and Quality patient safety program. Frontline caregivers in 100 NICUs in nine states relied on the program's prevention practice checklists and better communication to prevent an estimated 131 infections and up to 41 deaths and to avoid more than $2 million in health care costs.

CLABSIs are healthcare-associated infections (HAIs) that cause serious illness and death in infants as well as adults. A central line is a tube (catheter) that goes into a patient's vein or artery and ends in the central bloodstream. In newborns, especially premature infants, central lines can remain in place for weeks or months to provide nutrients and medications as babies become able to function on their own.

Health care teams in the project states, caring for a total of 8,400 newborns, used AHRQ's Comprehensive Unit-based Safety Program (CUSP) to improve safety culture and consistently implement catheter insertion and maintenance guidelines. CUSP is customizable and helps hospitals understand and apply the science of safety and take actions to improve teamwork and communications. This 11-month project used CUSP to help clinical teams focus on safe practices and appropriate steps when using central lines based on guidelines from the Centers for Disease Control and Prevention.

Each state-based team was led by a neonatologist who worked with the state's hospital association to implement the project. When the project began, participating NICUs had an overall infection rate of 2.043 per 1,000 central line days. At the end of the project, that rate was reduced to 0.855 per 1,000 central line days, a relative reduction of 58 percent. For more information on how NICUs achieved this reduction, visit http://www.ahrq.gov/qual/clabsi-neonatal/.

"The CUSP framework brings together safety culture, teamwork and best practices—a combination that is clearly working to keep these vulnerable babies safer," says AHRQ Director Carolyn M. Clancy, M.D. "These remarkable results show us that, with the right tools and dedicated clinicians, hospital units can rapidly make care safer."

The nine-state project in NICUs is part of a larger AHRQ-funded effort to implement CUSP to prevent CLABSIs nationwide. Preliminary results of the larger project were announced in September 2012; final results from the national implementation project are now available and show that CLABSIs were reduced by 41 percent in adult ICUs. The final report is available at http://www.ahrq.gov/qual/clabsi-final/.

AHRQ provided funding to the Health Research & Educational Trust (HRET), the educational arm of the American Hospital Association (AHA), to conduct both projects. For the NICU project, HRET partnered with the Perinatal Quality Collaborative of North Carolina and the Missouri Center for Patient Safety to support Colorado, Florida, Hawaii, Massachusetts, Michigan, New Jersey, North Carolina, South Carolina and Wisconsin.

"The successes of the project are proof that a great deal of improvement can happen in a relatively short timeframe," says Maulik S. Joshi, Dr.P.H., president of HRET and senior vice president of the AHA. "We are excited by the outcomes of the collaborative, and we look forward to applying what we've learned about leveraging existing infrastructures to spread improvement in ongoing and future projects."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis